Copyright
©The Author(s) 2022.
World J Virol. Nov 25, 2022; 11(6): 477-484
Published online Nov 25, 2022. doi: 10.5501/wjv.v11.i6.477
Published online Nov 25, 2022. doi: 10.5501/wjv.v11.i6.477
Table 2 Comparison of tracheostomy-related events between survivors and non-survivors
| Parameters | Survivors | Non-survivors | P value | |
| Age (yr) | 44.95 ± 4.19 | 54.84 ± 2.05 | 0.02 | |
| Gender male | 12 (57.2%) | 26 (50%) | 0.38 | |
| Female | 9 (42.8%) | 26 (50%) | ||
| Comorbidities | Present | 06 (28.6%) | 16 (30.77%) | 0.54 |
| Absent | 15 (71.4%) | 36 (69.23%) | ||
| COVID severity | Mild | 10 (71.4%) | 04 (28.6%) | 0.001 |
| Moderate | 03 (13.6%) | 19 (86.4%) | ||
| Severe | 08 (21.6%) | 29 (78.4%) | ||
| Admission to tracheostomy (d) | 17.09 ± 2.54 | 18.53 ± 1.88 | 0.67 | |
| Intubation to tracheostomy (d) | 9.19 ± 8.57 | 13.09 ± 9.02 | 0.01 | |
| Early tracheostomy (< 10 d) | 14 (66.6%) | 21 (40.3%) | ||
| Late tracheostomy (> 10 d) | 7 (33.4%) | 31 (59.6%) | 0.03 | |
| ICU stay (d) | 26.19 ± 3.50 | 24.55 ± 1.41 | 0.6 | |
| Hospital stay (d) | 30.85 ± 3.15 | 27.15 ± 1.41 | 0.21 | |
- Citation: Singh Y, Soni KD, Singh A, Choudhary N, Perveen F, Aggarwal R, Patel N, Kumar S, Trikha A. Clinical characteristics of COVID-19 patients who underwent tracheostomy and its effect on outcome: A retrospective observational study. World J Virol 2022; 11(6): 477-484
- URL: https://www.wjgnet.com/2220-3249/full/v11/i6/477.htm
- DOI: https://dx.doi.org/10.5501/wjv.v11.i6.477